SCHEMBL4927301

SCHEMBL4927301

Cc1cc(=O)oc2ccc(N3C(=O)c4ccccc4C3=O)c(CCO)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.39
▸ MEN1 O00255 6/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ GAA P10253 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ MAPT P10636 4/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ GRM1 Q13255 1/20 0.37
▸ GRM4 Q14833 1/20 0.37
▸ PDCD1 Q15116 1/20 0.37
▸ CD274 Q9NZQ7 1/20 0.37
▸ TSHR P16473 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ ESR2 Q92731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14088053 0.83 MAPT (0.39) ALDH1A1MEN1KMT2AGAALMNA
SCHEMBL4924821 0.83 VKORC1 (0.39) ALDH1A1MEN1KMT2AGAALMNA
SCHEMBL14088024 0.78 ALDH1A1 (0.46) ALDH1A1KMT2AGAALMNAHPGD
SCHEMBL4925486 0.74 ALDH1A1 (0.43) ALDH1A1KMT2AGAALMNAHPGD
SCHEMBL15842685 0.65 MAPT (0.56) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL14088023 0.64 ALDH1A1 (0.41) ALDH1A1KMT2AGAAHPGDHTT
SCHEMBL4197724 0.64 SCN2A (0.42) ALDH1A1KMT2AGAAHTTMAPT
SCHEMBL1904159 0.64 NR1H3 (0.68) ALDH1A1PDCD1CD274SMN1; SMN2CASP1
SCHEMBL30228504 0.63 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AGAAHPGD
SCHEMBL4929370 0.63 CA9 (0.61) ALDH1A1MEN1KMT2AGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT ALDH1A1 181/4885MEN1 1950/4885KMT2A 1156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback